WCN26-8632 DIAGNOSTIC PERFORMANCE OF BETA-2-MICROGLOBULIN COMPARED WITH TRADITIONAL MARKERS IN DETECTING EARLY KIDNEY DISEASE AMONG ELDERLY PATIENTS AT ALEX EKWUEME FEDERAL UNIVERSITY TEACHING HOSPITAL, ABAKALIKI

Read full text Summarise with VIRAT
Authors: Anthony C. Agbo, Ngozi A. Ifebunandu, Olaronke F. Afolabi, Ugochi Chika Onu, Monday Ume Nwobodo, Chinedu Udeze, Christiana Ologwu, Onyinye J. Nwikwu, Ifeoma Ulasi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chronic kidney disease (CKD) is a growing global health burden, particularly in ageing populations. Early detection and initiation of appropriate management are key to halting progression to kidney failure. Conventional biomarkers such as serum creatinine and urine albumin-to-creatinine ratio (UACR) are limited by dependence on muscle mass and other physiological variables. Beta-2-microglobulin (β2M) has emerged as a potential alternative marker of kidney function, relatively unaffected by age, sex, or muscle mass.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Acute Kidney Injury Research Dialysis and Renal Disease Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104541–104541
Publication date
25 March 2026
Language
EN